FDA Import Refusal 8JB-0093850-4/11/68 — AbbVie Inc.
The FDA refused shipment 8JB-0093850-4/11/68 from AbbVie Inc. (United States) on Mar 22, 2023. The refused product falls under Drugs and Biologics — LEVOTHYROXINE SODIUM (THYROID HORMONE). Cited charge: 179 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 22, 2023
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 66JDA01 LEVOTHYROXINE SODIUM (THYROID HORMONE)
- Charges
- 179